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'Resculpting'the Cornea 
Equipped with the latest technology 
that enables them to map out the 
cornea, eye surgeons at Boston 
University Medical Center Hospital 
are performing an improved surgical 
technique to combat astigmatism. In 
doing so, they are helping to restore 
the vision of those who suffer from 
this common yet disabling ocular 
problem. 
PAGE O 
Treating Complex Skin Diseases 
Unti l recently, patients with 
pemphigus or pemphigoid—painful 
and potentially fatal blistering diseases 
of the skin—had few places to turn for 
an accurate diagnosis and successful 
treatment. Now, a team of BUMCH 
clinicians and researchers is providing 
new medical hope to these individuals. 
PAGE C 
Nursing's 'Critical'Players 
Meet BUMC Hospital's Joan Vitello, 
RN, MSN, the new leader of the 
American Association of Critical Care 
Nurses (AACN), who shares her views 
on nursing's role in health care reform, 
and describes her goals for the AACN. 
PAGE T 
Skin-Cancer Survivor 
He is the perfect picture of health. 
Yet, several years ago, Norwood 
firefighter Harvey EeBlanc nearly lost 
his nose—and his life—to recurrent 
skin cancer. That is when he sought 
out the collaborative efforts oi 
BUMCH dermatologists and surgeons, 
who treat difficult skin cancers in a 
way that results in minor cosmetic 
effects and better than a 95-percent 
chance that the cancer w i l l not return. 
New Imaging and Intervention 
From improving angioplasty to 
detecting various cancers, members oi 
BUMCH's Department of Radiology 
are taking advantage oi new technolo-
gies and techniques to better care for 
patients. 
PAGE 12 
News & Names 
Staff awards, appointments, 
honors...Boston University opens its 
Center for Advanced Biomedical 
Research...Clinton health care reform 
plan is focus oi BUMC 
forum...Hospital breaks ground for 
new outpatient dialysis facility...73 
MDs recognized for service anniversa-
ries. 
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n the late 198Os, Geraldine
Comors, 85, reCeived
transplants in both of her
eyes to replace her failing
The stlrgery, COnducted by
SurgeOnS at Boston Universlty
Medical Center Hospital′s
Gundersen Eye Center, SaVed her
Vision. ‘‘My sight YOuld have
gone away without lt,′′ says the
Milton resident.
’However, the treatment left the
Shape of the patient′s new comeas
SOmeWhat distorted, a COndition
Ca11ed astigmatism that is a
common result of this sort of
Surgery. As a result of that
PrOblem, Comors had to wear
contact lenses. Hard lenses were
the only ones that were appropri-
ate for her, however, and it tumed
Out that they fit comfortably only
in Comors′ right eye. /‘When I
tried to put the contact in my left
eye, I couldn′t wear it,′′ she
recalls.
Earlier this year, Comors′ eye
doctor suggested that she consider
an improved surgical technique for
astigmatism that was being
offered at BUMCH. Connors
agreed.
The treatment, Called astig-
matic keratotomy, tumed out to
be both simple and effective.
/‘There was no pain, and it was all
OVer in five or lO minutes,′′ she
SayS. ‘‘And when I went back to
be tested, my Vision was almost
20/20 in that eye.′′
BUMCH is one of only three
medical centers in Boston that
BY RICHARD P. ANTHONY
Performs computer-guided astig-
matic keratotomies. The proce-
dure, W ich invoIves surgically
‘/resculpting′′ the comea, rOughly
resembles a procedure for near-
Sightedness known as radial
keratotomy. The two treatments
are not identical, though, and their
differences reflect differences
between the problems being
treated, SayS John P. Frangie, MD, a
member of the BUMCH Depart-
ment of OphthalmoIogy and the
Surg On Who treated Comors.
Frangie, Who started doing
as igmatic keratotomies in 1991,
SayS a large proportion of the
individuals who qualify for the
A血ge
p重αタ0ば也0かげ血e
五億竜d暮重a応w五o
q放く叫か1缶血e
p調 ed櫨がe心ave
as軸a出血
でes心血g加畑
Ca虞躍動Ct S耽管∽y
PrOCedure have astigmatism
resulting from cataract surgery.
‘‘Up to 42 percent of patients
tre ted f r cataracts experience
Significant astigmatism in the.
treated ey ,′′ he notes. Patients
Who have had comeal transplants
also represent a significant percent葛
age of thos  qualifying for astig-
matic keratotomies, aS they tend to
have a higher incidence of astigma-
In ne rsightedness′ eXplaini
Frangie, the comeal curvature lS SO
great that light passing through the
COmea Will not focus shaxply on
the retina-the tissue at the back
Of the eye that is the eye′s equiva-
1ent to the film in a camera. To
COrreCt.nearSightedness′ a SurgeOn
makes mCisions that radiate out
from the pupi1 1ike a star burst.
The cisions, Which go o血y
PartWay through the comeal tiss早
have the effect of slightly flattemng
the comea, thus making it possible
for light passing through the tissue
to be focused on the retina.
Astigmatism also is caused by
abnormal comeal curvature, but of
a different nature. ‘/A perfect
comea is a dome that has the same
CurVature in all directions, ′′ says
Frangie. ‘/With astigmatism, the
dome is distorted more toward a
footba11 shape. ′′
According to Frangie, mild
astigmatism is correctable with
glasses or contact lenses. In the
CaSe Of more severe distortions,
however, Which frequently occur
following comeal transplants and
CataraCt Surgery, glasses may not be
effective and contact lenses may be
unwea able.
In such cases, SayS Frangie, the
Only option in the past was to
Surgically re-OPen the eye, and re-
SeW th  reated area in such a way
as to leave he eye less distorted
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than before. The technique
SOmetimes works, he says. ′‘But
the predictability of the procedure
is not high and it can take up t? a
year for the patient to start seemg
better. ′′
Astigmatic keratotomy is
PrOVing to be a much simpler and
more reliable altemative than
COnVentional surgery. During this
PrOCedure′ rather than making
incisions in a star-burst pattem,
the surgeon makes small, tangen-
ial cuts in the steep meridian of
the com a臆uSua11y no more than
four per eye. These cause the steep
meridia  to flatten while the pexpen-
dicular region steepens slightly. The
re ult′ aS in Comors′ case, Can be a
JOr improvement in vision.
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Mapping outthe cornea 
But how does the surgeon know 
where the incisions should go? 
Frangie says that although the 
computer-guided procedure is 
only about five years old, sur-
geons have had enough experi-
ence w i t h i t to develop a series of 
treatment guidelines. For the 
guidelines to work, though, a 
surgeon has to know exactly 
where and how the eye is dis-
torted. Frangie uses a highly 
sophisticated system called a 
computer-videokeratoscope to 
reveal irregularities i n the eye's 
shape. 
The device's function can he 
compared to a beam of l ight that 
reveals the presence of wavelets 
when shone along the surface of a 
body of water. " I t projects a 
series of circles of l ight on the 
comea," explains Frangie, "and if 
your eye is not a perfect dome, 
the circles w i l l be distorted when 
they reflect off the comea." 
The system's computer, using 
7,000 hits of data accumulated 
from the reflected l ight signals, 
creates a color diagram that 
shows how the comea is dis-
torted. "The diagram tells me 
exactly where the abnormal 
curvature is , " says Frangie. 
"Thus, I use i t as a map i n doing 
the procedure." 
As vi ta l as knowing where to 
make the incisions is knowing 
how deep those incisions should 
be. Al though eye tissue is less 
than paper th in , Frangie can 
make an incision that goes 95 
percent of the way through the 
comea w i t h o u t puncturing the 
eye tissue. Among the keys to 
the technique's success, he says, 
are the various forms of instm-
mentation and technology 
available at the Medical Center. 
Frangie's scalpel, for example, is a 
sophisticated instmment whose 
diamond-tipped blade can be 
aligned w i t h i n a guide stmcture 
i n such a way that the blade w i l l 
penetrate to the depth desired and 
no further. I n addition, Frangie 
utilizes a magnifying system that 
enables h i m to see precisely how 
deeply the scalpel is penetrating. 
To make incisions of the right 
depth, the surgeon also needs to 
know ahead of t ime the thickness 
of the eye tissue. Frangie obtains 
'If there's a 
significant 
difference between 
the degree of 
astigmatism in a 
person's eyes, it can 
throw the person's 
sensory system out 
of balance.' 
this information using a specially 
designed ultrasound system. " I t 
can tel l me the depth of the tissue 
to w i t h i n one one-hundredth of a 
mil l imeter , w h i c h is about four 
ten-thousandths of an i n c h , " he 
says. 
Once he knows how the 
comea is distorted and its precise 
thickness, Frangie moves on to 
surgery. The procedure is short 
and painless. The patient lies on 
a couch. Frangie puts a numbing 
drop i n the patient's eye, and then 
makes the incisions. 
Patients undergoing astigmatic 
keratotomy can go home immedi-
ately fol lowing surgery. Al though 
they w i l l not feel pain, they may 
experience some discomfort for 
one or two days. " M y patients 
have told me that i t feels as 
though they have a grain of sand 
i n their eyes," he says, "hut I've 
never had anyone come hack i n 
because they were bothered by 
the feeling i n the treated eye." 
Frangie says that the procedure 
does not have the major drawback 
that is associated w i t h radial 
keratotomy, which is that some 
patients experience a glare effect 
when looking into l ight at night-
t ime. Since the incisions made 
during astigmatic keratotomy are 
done so along the side of the comea 
and not near the pupil , the scars 
from the operation do not signifi-
cantly dismpt the passage of l ight . 
Astigmatism, if severe, can have 
a negative impact on a person's 
sight and equil ibrium, " i f there's a 
significant difference between the 
degree of astigmatism i n a person's 
eyes, i t can throw the person's 
sensory system out of balance," 
explains Frangie. "I 've had patients 
te l l me that the table tops and 
counters and everything around 
them look slanted. I t can make 
them feel dizzy and unstable." 
Astigmatic keratotomy is not 
the answer for all such patients, 
however. I n certain individuals, 
the distortion of the eye is simply 
too great to be corrected w i t h 
surgery. For those who do qualify 
for the procedure, though, the 
outlook is excellent. " I n 100 
percent of our cases," Frangie 
notes, "we've been able to achieve 
a significant reduction i n the 
astigmatism." 
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Dr. Frangie is 
on the staff 
of the 
Hospital's 
Department 
of Ophthal-
mology and 
is an assis-
tant professor of ophthalmology 
at Boston University School of 
Medicine. 
If you would like more informa-
tion on astigmatic keratotomy or 
on any other ophthalmologic 
services offered at BUMCH, 
please call 617/638-6767 during 
business hours. 
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i s i^ti l recently, people 
i f suffering from 
"Sf/ pemphigus or 
^ pemphigoid—painful 
and potentially fatal 
autoimmune diseases of the skin 
and mucous membranes—had few 
places to t u m for an accurate 
diagnosis and successful treat-
ment. 
However, this situation is 
changing, thanks i n part to the 
efforts of A. Razzaque Ahmed, 
M D , DSc, one of the world's 
foremost authorities on these 
diseases. Ahmed, a member of 
Boston University Medical Center 
Hospital's Department of Derma-
tology, heads the only team i n 
N e w England and one of just a few 
groups i n the country specializing 
i n the diagnosis and treatment of 
pemphigus and pemphigoid, w h i c h 
cause blisters on the skin that can 
have life-threatening conse-
quences, i n addition to rendering 
precise and often immediate 
diagnoses, he is pioneering new 
treatments that promote longer 
remissions, fewer side effects and a 
better quality of life for patients. 
Ahmed also heads a research team 
that is investigating what causes 
blistering diseases l ike pemphigus 
and pemphigoid, and w h y certain 
people are more susceptible to 
them than others. 
i n the 1950s, almost all patients 
w i t h pemphigus and pemphigoid 
died, usually f rom pneumonia or 
blood infections that occurred 
fol lowing skin infections. While 
the mortal i ty rate has dropped to 
10 or 15 percent, death occurs now 
as m u c h from the side effects of 
BUMCH 
team offers 
newhope 
for two 
serious skin 
diseases 
BY WENDY LAVALEEE 
inappropriate treatment as f rom 
the effects of the diseases. 
Misdiagnoses common 
Pemphigus is a relatively rare 
disease, affecting about one i n 
100,000 people, and i t generally 
occurs i n people i n their 50s and 
60s. W i t h pemphigus, the 
intercellular substance that 
'glues' together the cells of the 
epidermis—the skin's outer 
layer— is dissolved by an anti-
body produced by the patient. 
The result is the development of 
blisters on the skin's outer 
surface that break easily, leaving 
the skin denuded l ike a peeled 
tomato. 
A t least twice as common as 
pemphigus, pemphigoid usually 
affects the elderly,- the great 
majority of patients are over 65 
years old. W i t h a significant 
increase i n the number of people 
over that age i n the United States 
i n recent years, pemphigoid is 
appearing more frequently i n this 
country than ever before. 
W i t h pemphigoid, the patient 
produces an antibody that acts 
against a skin basement membrane 
protein, causing a split at the junc-
t ion of the epidermis and the dermis. 
This split causes large blisters that 
are taut and f u l l of f lu id . 
Once treatment has begun, the 
symptoms of the diseases usually 
disappear w i t h i n a few weeks. 
When the diseases are i n remission, 
the previously affected areas re tum 
to their normal state. Relapses 
occur about 33 to 50 percent of the 
t ime. 
While early diagnosis of both 
diseases often allows for a good 
response to treatment, the diseases 
are often misdiagnosed at first, i n 
fact, patients typically see more than 
five doctors before receiving an 
accurate diagnosis and frequently 
the diseases are confused w i t h cold 
sores, fungal or bacterial infections, 
irr i tant or allergic reactions, eczema 
or other skin diseases. 
Treatment traditionally for both 
conditions has involved prolonged 
high-dose systemic corticosteroid 
therapy, which often results i n 
remission. However, whi le effec-
tive, this mode of treatment often 
causes serious side effects, including 
peptic ulcers, diabetes and high 
blood pressure. 
Ahmed is adept both at recogniz-
ing the symptoms of the diseases 
and rendering accurate diagnoses. 
He's also developed a different 
approach to treatment, w h i c h 
involves using l imi ted amounts of 
steroids, such as prednisone, giving 
patients injections directly into the 
blisters or intralesionally, and 
employing antineoplastic agents. 
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such as Cytoxan, and immuno-
suppressive agents, such as 
Imuran. "I moved to this 
treatment regime five or six 
years ago, hecause the side 
effects of the long-term use of 
high doses of systemic steroids 
is catastrophic," Ahmed says. 
"By injecting intralesionally, 
the side effects are minimized. ' 
To treat patients w i t h 
pemphigoid, Ahmed often 
prescrihes dapsone, a drug used 
to treat leprosy, i n addition to 
systemic corticosteroids. 
However, he says, "There is no 
physiological connection 
hetween the two diseases. Since 
dapsone is an anti-microbial, i t 
k i l l s the bacteria that causes 
leprosy. But i t also has an anti-
inflammatory effect, which is w h y 
i t works i n pemphigoid." 
Treating the individual 
One of Ahmed's patients, Debbie 
Stillman, 58, a Boston homemaker 
who first developed pemphigus i n 
May 1989, is a f i r m believer i n his 
treatment methods. 
Stil lman came to Ahmed i n 
August 1989, after having her 
disease misdiagnosed at two other 
institutions twice—first as herpes 
and then as shingles. She had 
heard about Ahmed from a derma-
tologist who was a friend of a 
friend. "By the t ime 1 saw Dr. 
Ahmed, the disease had spread 
f rom m y m o u t h to m y entire body, 
if they had caught i t early enough, I 
wouldn' t have ended up looking 
the way 1 looked," she says. 
Ahmed, having diagnosed her 
immediately, hospitalized Sti l lman 
for two weeks whi le he began her 
on treatments of small doses of 
prednisone, administered 
intralesionally. During treatment, 
the side effects were l imi ted and i n 
about eight months, the disease 
went into remission. When 
Stil lman suffered a relapse i n 1991, 
she was treated on an outpatient 
basis. " I never had to experience 
what I did the first t i m e , " she says. 
A 70-year-old male with extensive pemphigoid of the 
lower extremities (left); a 42-year-old female with 
severe extensive pemphigus involving the back. 
Stil lman says her experience at 
B U M C Hospital was excellent. 
" D r . Ahmed was there for me f rom 
the beginning and i t was a whole 
different ball game. To me, he's 
the most wonderful, caring, hu-
Patients typically see more 
than five doctors before 
receiving an accurate 
diagnosis. 
manistic being. He treats each 
person individually and not i n a 
run-of-the-mill manner." 
Finding the causes 
Ahmed began his studies on 
pemphigus and pemphigoid about 
20 years ago, when he was a 
resident i n dermatology at the 
State University of N e w York at 
Buffalo, " i t was a challenge," he 
says. "These diseases can be fatal 
and are diff icult to treat. The 
patients are really sick and there 
are very few people working on 
these diseases." 
Today, Ahmed treats patients 
f rom around the world. I n fact, at 
least 20 percent are referred to h i m 
by physicians i n other countries. 
Another 20 percent come from 
outside N e w England. 
Ahmed heads a team of c l ini -
cians and researchers at B U M C H 
who are conducting their research 
under two grants f rom the Na-
tional Institutes of Health. 
Three years ago, the group 
identified the genes that 
predispose people to getting 
pemphigus and pemphigoid. 
"This doesn't mean that the 
diseases are genetically l inked, 
and i t doesn't mean that the 
genes cause the diseases," says 
Ahmed. "We don't yet know 
whether there's a causal 
relationship here. But i t does 
mean the presence of the gene 
facilitates the disease and 
provides enhanced susceptibil-
i t y . " 
Under Ahmed's direction, 
each team member is conducting 
his or her own line of research. 
"The two fundamental questions 
we are asking are, 'Why does 
someone get this disease?' and, 'If 
someone is predisposed to getting 
the disease, what are the mecha-
nisms that cause the disease? H o w 
is the disease produced clinically?'" 
Ahmed says. 
Results of Ahmed's original 
research have been published i n 
numerous respected medical 
joumals such as the Proceedings of 
the National Academy of Sciences, 
the Journal of Experimental 
Medicine and the Journal of 
Investigative Dermatology. 
FOR YOUR IN FORMA TION 
Dr. Ahmed is 
on the staff of 
the Hospital's 
Department of 
Dermatology ji 
and a profes-
sor of derma-
tology at 
Boston University School of 
Medicine. He is also a professor of 
oral biology and peridontology at 
Boston University's Goldman 
School of Graduate Dentistry. 
If you would like more informa-
tion on his work, please call 617/ 
638-6767 during business hours. 
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Nursing's 'critical' players 
An interview with the nation's top critical care nurse 
QlePlA 
BUMCH critical 
care clinical 
nurse specialist 
Joan Vitello, 
RN, MSN, 
recently was 
named presi-
dent-elect of 
the American 
Association of 
Critical Care 
Nurses (AACN), the world's largest 
specialty nursing organization, in July, 
she will become its 25th president, 
in the following interview with Progress 
writer Kathryn Jones, Vitello shares her 
views on the important role that nurses 
will play in restructuring health care and 
describes her goals for the AACN. 
Progress: What impact do you think 
health care reform w i l l have on 
nursing and, more specifically, on 
critical care nursing? 
Vitello: I think the impact on nursing 
in general w i l l he a need for more 
nurses, and for those nurses to func-
tion in different types of settings. 
Because the focus of health care reform 
is to shift from a system that is hased 
on illness to one that is hased on 
promoting wellness, there w i l l he an 
increased need for nurses in the 
primary care and health-promotion 
service arenas. There also w i l l he an 
increased role for nurses with advanced 
degrees to deliver direct patient care in 
rural and under-served primary care 
settings. 
As far as critical care nursing is 
concerned, I think there w i l l always he 
a need for this type of specialty 
hecause of the numbers of people who 
become critically i l l and critically 
injured each year and because we have 
an elderly population that w i l l 
gradually develop many health 
problems. 
Looking toward the future, I think 
that interdisciplinary conflicts within 
the medical field w i l l escalate, 
unfortunately, as we all try to sort out 
what type of health care professional 
should provide primary care in a 
reformed health care system. How-
ever, I would like to see all of us stay 
focused on meeting the patients' needs 
and delivering the highest quality of 
health care in the most cost-effective 
manner. 
Progress: How might nurses survive 
and, indeed, thrive during this period 
of change? 
Vitello: I think that nurses, especially 
those at major teaching institutions 
like BUMCH, w i l l have to become 
more accountable and take on in-
creased responsibility as the number of 
resident physicians in acute care 
dwindles due to the move toward 
primary care. In the meantime, I 
believe that nurses have to refocus the 
way they deliver care. Here at 
BUMCH, the surgical intensive care 
unit has formed a task force to look at 
new and innovative ways of providing 
patient care. I , for one, am extremely 
happy to he a part of this visionary 
"think tank." Within the next few 
months, we w i l l he proposing major 
changes in the way patient care is 
delivered. 
Progress: How is the A A C N helping 
to chart the direction of health care 
reform? 
Vitello: The A A C N has endorsed 
President Clinton's plan and has 
increased its grass-roots' legislative 
efforts to help make the plan a reality. 
It is also asking its members to help 
promote universal access, not only to 
primary health care hut to critical care 
as well. 
In addition to promoting universal 
access, the AACN is trying to mini-
mize the need for emergency care. To 
this end, its members are working 
closely with state legislators, devising 
policy that w i l l help rid its urban and 
rural areas of violence, since violence 
results in many critical care patients. 
Lastly, the A A C N is working in 
collaboration wi th all of the other 
nursing specialty organizations to 
discuss just exactly what nursing's role 
w i l l he in a reformed system. 
Progress: How w i l l you, in your 
upcoming term as A A C N president, 
help to chart the direction of the 
organization? What are your goals? 
Vitello: My first goal is to educate 
health care consumers about advance 
directives. Under the federal Patient 
Self-Determination Act, hospitals are 
now legally mandated to discuss 
advance directives with patients at the 
time of their admission to the hospital. 
Ideally, the A A C N would like to see 
these discussions occur before a patient 
is admitted or, better yet, before a 
person becomes critically i l l . To help 
make this happen, the A A C N w i l l soon 
initiate a national project aimed at 
encouraging people to discuss advance 
directives while they're still healthy. 
Under the project, members of our 286 
chapters w i l l establish formal relation-
ships wi th such community groups as 
the Lions' Clubs, churches and schools. 
My second goal as A A C N president 
is to promote leadership development 
among our 78,000 members. I believe 
that every critical care nurse is capable 
of being a leader, starting at the 
patient's bedside. By exposing nurses 
to outstanding leaders in other profes-
sional fields and by sharing my own 
professional experiences, I feel that I 
can assist nurses in developing the 
necessary competencies and qualities 
they need to he strong and effective 
leaders. 
My third and final goal is to actual-
ize AACN's vision of having a health 
care system that is truly driven by the 
patients' needs. 
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of 
well-being 
has been 
restored' 
feing diagnosed with cancer is 
disturbing enough without the added 
prospect of being permanently 
disfigured from the surgery. However, 
such was the case for Harvey LeBlanc, 
a Norwood firefighter, who was 
diagnosed with squamous-cell 
carcinoma of the nose more than five 
years ago. 
After his first round of medical 
treatment, LeBlanc's tumor recurred. 
He then had the tumor surgically 
removed by a specialist and received 
doses of radiation therapy to com-
pletely destroy any remaining cancer 
cells. Once again, however, the 
cancer recurred, spreading even 
further throughout his nose. Seriously 
deformed with nearly 75 percent of 
his nose lost to the cancer and still 
stricken with the disease, LeBlanc 
sought out Gary S. Rogers, MD, a 
dermatologic surgeon and co-director 
of Boston University Medical Center 
Hospital's Skin Oncology Program. 
"The damage from the cancer was 
so extensive that part of Mr. 
LeBlanc's sinus was exposed where 
his nose should have been," says 
Rogers. 
Rogers performed a delicate 
procedure known as Mohs micro-
graphic surgery to remove LeBlanc's 
entire tumor with minimal sacrifice 
of healthy tissue to the patient's nose 
and face. Following that procedure, 
he referred LeBlanc to Nabil 
Fuleihan, MD, a BUMCH head and 
neck and facial plastic surgeon, and 
chief of the Hospital's Department of 
Otolaryngology. 
Fuleihan performed reconstructive 
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Multidisciplinary program 
offers skin-cancer patients 
minimal trauma, maximum results 
BY MICHAEL R. PASKAVITZ 
-Patients l ike Harvey LeBlane who 
are diagnosed w i t h skin cancer of 
the face and neck historically have 
had l i t t le choice hut to undergo 
treatment that often resulted i n 
severe cosmetic disfigurement, 
w i t h l i t t l e assurance that their 
tumors would not recur. 
But now, a more desirable 
option is being offered at B U M C H , 
where dermatologists and surgeons 
are collaborating to treat diff icult 
skin cancers i n a way that results 
i n only minor cosmetic effects and 
better than a 95-percent chance 
that the cancer w i l l not return. 
The collaborative approach draws 
on the expertise of a number of 
medical disciplines. 
'We deal with complex 
tumors that no one 
specialist could handle 
alone. If you want optimal 
results, a coordinated 
approach is best.' 
"We deal w i t h complex tumors 
that no one specialist could handle 
alone," says Rogers. " I f you want 
optimal results, a coordinated 
approach is best." Such an ap-
proach has yielded remarkable 
results, leading to the cure of 99 
percent of patients w i t h primary 
basal-cell cancers and 95 percent of 
those w i t h primary squamous-cell 
tumors. A n added benefit is that 
the treatment causes m i n i m a l 
sacrifice of healthy tissue. 
"The range of disciplines offered 
through this service is very 
complementary," says Fuleihan. 
"To produce the best outcome for 
patients, most skin cancers of the 
face require input f rom dermatol-
ogy, oncology, head and neck 
surgery, facial plastic and recon-
structive surgery and radiation 
oncology. This service coordi-
nates all of them into one central-
ized service." 
Established i n 1987, the 
service is coordinated by Rogers 
and Fuleihan. I t recently has 
been expanded to involve other 
departments that treat these 
patients, including prosthetics 
and psychiatry. 
The lesser-known skin cancers 
About 90 percent of Rogers' and 
Fuleihan's skin-cancer patients 
have either basal-cell or squa-
mous-cell carcinoma that has 
been treated at other institutions, 
but has recurred or not responded 
to conventional therapy. A l -
though these tumors are less 
k n o w n than the more threaten-
ing form of skin cancer, malig-
nant melanoma, they are more 
prevalent, afflicting nearly 
600,000 Americans each year. 
Unfortunately, these typically 
non-life-threatening cancers carry 
a greater threat of spreading when 
they appear i n sensitive areas, 
such as the face, eyes, nose, or 
mouth. 
"We've had patients w i t h very 
small lesions on their cheek or 
nose that, because the lesions 
were incompletely removed and 
recurred, now extended back into 
their sinus," says Rogers. "So 
these skin cancers can be very 
deceptive. 
"The recurrence rate for the 
conventional treatment of basal-
cell and squamous-cell carci-
noma, the two most common 
skin cancers, is only about 6 to 7 
percent," he explains. "But that 
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Mohs micrographic surgery 
The cancerous tissue is excised 
and taken to the laboratory. (A) The edges 
of the tissue are flattened, in order to 
permit examination of the entire 
surgical margin. (B) The excised tissue is 
mapped, sectioned and examined 
microscopically to check 
for tumor "roots." (C) Areas of residual 
cancer are marked on the map, so that the 
surgeon can locate and remove the 
additional tissue. The entire process is 
then repeated until no residual 
tumor is present. 
By conventional "bread-loafing" of the 
excised specimen, only 5 percent of the 
surgical margin is examined. 
rate nearly doubles when these 
cancers appear on the face." 
The best available option 
According to Rogers, many skin 
cancers can be handled i n a doctor's 
office because the lesions tend to be 
found i n their early stages of 
development, when tumors are 
small and superficial. However, 
other skin cancers, because they are 
complex or recurrent, may be more 
diff icult to diagnose and treat. The 
skin-cancer surgery service offered 
at B U M C H deals w i t h these types 
of cancer typically i n two steps. 
First, the patient is evaluated and a 
treatment plan is chosen. One 
option, k n o w n as Mohs micro-
graphic surgery, is a unique tech-
nique performed by Rogers (see 
above diagram). I t is used to 
remove cancerous tissue and 
microscopically investigate i t for 
subcutaneous "roots," an indica-
t ion that the cancer may have 
spread elsewhere beneath the skin. 
Mohs surgery is typically the 
treatment method of choice should 
the skin cancers arise i n certain 
critical locations, are large, or have 
not responded to other conven-
tional therapies. 
Conventional treatments for 
cancers of this type include surgery 
to. excise the tumor, currettage and 
electrodesiccation (scraping and 
buming w i t h an electric needle), 
radiotherapy, cryosurgery (freezing) 
and topical chemotherapy. While 
these methods remain effective, 
Mohs surgery offers better out-
comes for certain patients. 
"Conventional surgical tech-
nique, even w i t h frozen section 
analysis, allows you to examine 
less than 5 percent of the tumor 
margins i n a large skin sample, so 
it's diff icult to f ind any potential 
tumor roots," Rogers explains. 
" O n the other hand, the Mohs 
technique allows us to investigate 
100 percent of the tumor margins." 
If cancer roots are found, the 
extent to w h i c h the tumor has 
spread is mapped out and the 
additional tissue is removed using 
the Mohs technique. Once all the 
cancerous tissue has been removed 
and if v i ta l stmctures are affected, 
Fuleihan performs reconstructive 
surgery to repair the defect left by 
the cancer—the second and f inal 
step i n the treatment process. 
"The extremely high cure rate 
for Mohs surgery is exceptional 
given that most patients we see 
have recurrent tumors ," says 
Rogers. 
Restoring appearance 
Following conventional surgery, 
Fuleihan's challenge of restoring a 
person's appearance is often a ta l l 
order. However, the advent of 
Mohs surgery has made his job 
easier and patient outcomes more 
desirable. 
"The Mohs technique offers a 
tremendous advantage, i n that all 
of the tumor margins are investi-
gated at the t ime of excision," says 
Fuleihan, therefore precluding the 
need for additional excisional 
surgery. " I n addition, i t also 
ensures that the skin flaps used for 
reconstruction are free of tumor 
cells as w e l l . " 
Fuleihan explains that different 
areas of the face—called "aesthetic 
units"—have different tissue 
needs. "Sometimes fol lowing 
surgery to excise tumors, tissues 
have to be brought f rom other 
areas of the body" for reconstruc-
tive purposes, says Fuleihan. "But 
for the best results, those tissues 
have to be compatible i n texture, 
thickness, and color." 
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Some unnoticed or untreated 
skin tumors eventually can lead to 
other problems that require 
Fuleihan's expertise. I n about 5 
percent of cases, a more complex 
surgery is needed to remove 
tumors that Rogers has found to 
have entered the inner stmcture of 
the eyes, sinuses, mouth, or 
important nerve branches. 
I n such cases, where tumor 
roots have spread and developed i n 
sensitive areas of the face, 
Fuleihan and Rogers must perform 
delicate surgery to remove the 
tumors whi le not exacerbating the 
damage caused by the cancer. 
"When addressing cosmetic issues 
i n certain cases, we f ind we have 
to work on functional aspects of 
the face, such as freeing nasal 
passages or reconstmcting nerves 
damaged by tumors," says 
Fuleihan. 
• FOR YOUR INFORMATION 
Dr. Rogers is 
co-director of 
the Hospital's 
Skin 
f,^ Oncology 
Program and 
an associate 
professor of 
surgery and dermatology at 
Boston University School of 
Medicine. 
Dr. Fuleihan 
is chief of the 
Department 
of 
Otolaryngology 
and an 
associate 
professor of 
the School of 
If you would like more informa-
tion on BUMCH's skin-cancer 
surgery service, please call 
the BUMC Cancer HclpLink at 
I-800/524-854I. 
otolaryngology at 
Medicine. 
Making headway on several fronts 
While BUMCH's service in skin-cancer surgery offers patients with 
complex skin cancers a chance to become healthy and look normal, 
malignant melanoma, because of the higher risk of systemic spread, 
remains a public health menace with no proven method to cure it. 
Progress, however, is being made in preventing melanoma from 
metastasizing. 
Physicians affiliated with the BUMCH service have begun to move into 
hold new areas, applying new techniques to high-risk malignant 
melanoma patients on an experimental basis. 
M Gary S. Rogers, MD, and Howard K. Koh, MD, co-directors of the 
BUMCH Skin Oncology Program, are collaborating on an advanced 
protocol from the Southwest Oncology Group (SWOG), a major multi-
institutional drug testing program. The study is one of a number of 
advanced SWOG research projects in which BUMCH cancer physicians 
are involved. 
Under this protocol, Rogers evaluated a 40-year-old male patient with 
metastatic malignant melanoma; Robert Beazley, MO, chief of surgical 
oncology, removed tumors in the patient's lymph nodes, and Arthur 
Rosiello, MO, a BUMCH neurosurgeon, removed a suspicious area on the 
patient's skull. After these surgeries, the patient was started on 
interferon therapy, an experimental immunological treatment that helps 
destroy any remaining cancer cells, as part of a World Health 
Organization study. 
M Rogers also is working with BUMCH colleagues Koh and Evan 
Voshurgh, MO, a hematologist, on the study of a potential vaccine 
therapy for patients at high risk for developing metastatic melanoma. 
M Finally, Rogers has entered the next phase of study in clinical trials 
of Boron Neutron Capture Therapy (BNCT). This promising hut highly 
experimental therapy may help patients with metastatic melanoma where 
other therapies fail. It involves the patients drinking a solution containing 
a stable isotope of boron linked to an amino acid. To a cancer cell, this 
solution looks like tyrosine, one of the building blocks of melanin. Thus, 
the boron is absorbed by cells trying to make melanin. Several hours 
after drinking the solution, patients are exposed to a specially isolated 
neutron beam. Nuclear fission occurs when the neutrons encounter the 
boron, and an intense hut highly localized radiation is released. The 
radiation causes almost total destruction of boron-containing cancerous 
tissue in a very limited area, while sparing normal cells that have virtually 
undetectable concentrations of the boron isotope. 
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n medicine, new technolo-
gies tend to get headlines 
when they are first intro-
duced. 
That happened w i t h 
ultrasound, a technology i n 
w h i c h high-frequency sound 
waves bounced off intemal 
organs produce images of these 
targets, when i t was introduced 
i n the 1950s. I t happened w i t h 
the CT (computerized 
tomography) scanner, a special 
type of x-ray system that was 
developed i n the 1970s. A n d i t 
happened i n the 1980s w i t h 
magnetic resonance imaging 
(MRl), w h i c h can pinpoint some 
problems even C T scanners 
cannot f ind. 
Yet many new technologies 
realize their f u l l potential only 
years after being introduced— 
the result of improvements i n 
the technologies themselves, 
and i n techniques for using 
them. What follows are ex-
amples of some of the advances 
that members of Boston Univer-
sity Medical Center Hospital's 
Department of Radiology are taking 
advantage of i n diagnosing and 
treating patients. 
Imaging arteries 
A clogged artery is a serious prob-
lem. I n the brain, a wandering 
blood clot that gets stuck i n such 
an artery can cause a stroke. I n a 
coronary artery—a vessel that 
serves the heart muscle—such a 
clot can lead to a heart attack. 
To detect clogged arteries, 
physicians use a conventional 
technique called angiography. I t 
involves pumping x-ray contrast 
f lu id into a blood vessel, then x-
raying the vessel. 
Yet whi le the technique works 
wel l , E. Kent Yucel, M D , director of 
vascular radiology and M R l at 
B U M C H , says i t also entails a 
certain slight risk. M u c h of the 
risk, he explains, stems from 
potential damage to the arteries 
involved. The f lu id used i n the 
procedure is pumped through a 
catheter—a th in , flexible tube that 
is usually inserted through a leg 
artery and worked up from there to 
the target vessel. During the 
insertion process, Yucel explains, 
"You can injure the artery; you can 
also injure the target artery." 
Conventional angiography's 
risks, whi le low, have spurred the 
search for new altematives. M R l 
angiography is one of the most 
promising. 
M R l angiography differs f rom 
conventional angiography i n both 
its form and function. Because i t 
involves the use of x-rays, tradi-
tional angiography necessitates the 
use of a contrast f l u i d i n order to 
make the blood vessels visible to x-
rays. M R l angiography, on the 
other hand, relies on variations i n 
the natural chemical makeup of 
different parts of the body, or i n 
their state of motion, to pinpoint 
areas of disease or injury. 
Yucel notes, for example, that 
since blood moves, i t emits differ-
ent signals than those sent out by 
stationary tissue. "Blood is bright 
whi le the tissue around the vessel is 
darker," explains Yucel. "By 
maximizing that contrast, we can 
make a picture that shows abnor-
malities i n the vessel w a l l . " 
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M R l angiography is heing used at 
B U M C H to detect clogged arteries 
i n some regions of the body. " M R l 
scanning of brain and neck arteries 
is more or less routine," notes 
Yucel. "But that's hecause M R l 
works best when the target tissues 
don't move much. The heart area, 
where vessels are affected by the 
heating of that organ, is a tougher 
challenge." Before the technique 
can work for targets l ike the coro-
nary arteries, there w i l l need to be 
more advances—including faster 
computers. 
Computer speed is critical to 
improving the quality of the images 
produced and allows for more 
detailed scrutiny. M R l images of 
arteries can he composed of tens or 
hundreds of cross sections or 
"slices." Checking a foot-long 
stretch of artery i n the thigh, for 
example, might require 100 or more 
separate scans, each one about an 
eighth of an inch thick. " I n a slice, 
the vessels show up as bright dots 
against the darker surrounding 
tissues," says Yucel. "When the 
computer puts the slices together, 
the dots t u m into tubes. Those are 
the blood vessels." 
Making thinner slices improves 
image quality. But so does paring 
the t ime needed to scan each cross 
section, since that reduces move-
ment-related blurriness. 
Yucel has already seen a lot of 
progress i n this area. "Ten years 
ago, processing a single M R l 
angiogram used to take 12 hours of 
computer t i m e , " he notes. "Today, 
that same process w o u l d take five or 
six minutes. Of course, what you do 
is to take advantage of that added 
speed to get more detail ." 
Though further progress is 
needed before M R l systems can 
yield good images of small arteries 
near a beating heart, Yucel believes 
that M R l w i l l someday soon estab-
lish a significant role for itself i n 
imaging coronary arteries. "We'd 
l ike to be able to use M R l scans to 
screen people who are k n o w n to be 
at risk for coronary artery disease," 
he notes. " I f their larger arteries— 
f 
A magnetic 
resonance ''-vs'-is 
angiogram of a G'^^ 
patient with a ' 
severely narrowed I^m 
carotid artery (as , k . jPB 
indicated by the . T ^ j ^ m 
arrow}. Surgery • '•^ff l f 
was performed on - S I 
the basis of this 
image without the ^SiBiiiiiMil 
need for a 
conventional i 
angiogram. 
the ones we can see the best—are 
healthy, many of these patients 
won' t need conventional 
angiography." 
Improving angioplasty 
Over the past two decades, medi-
cine has seen a dramatic increase 
i n the popularity of a non-surgical 
technique for treating clogged 
arteries. Called balloon 
angioplasty, i t involves inserting a 
catheter w i t h a t iny, elongated 
balloon mounted on its end into 
the body, usually through a leg 
Computer speed is critical 
to improving the quality of 
the images produced and 
allows for more detailed 
scrutiny. 
artery. From there, the catheter is 
worked up to the target vessel and 
the balloon, once i t is i n the 
problem area, is then inflated two 
or three times to widen the vessel. 
Since individuals who qualify 
for angioplasty do not need bypass 
surgery, hospital stays can be 
drastically reduced. "We usually 
keep patients i n the hospital for 
one night , " says Robert 
D'Agostino, M D , a B U M C H 
radiologist who treats clogged 
arteries i n the legs and pelvis. 
Those same patients, if undergoing 
bypass surgery, would be hospital-
ized at least five to seven days. 
Yet whi le angioplasty helps 
many thousands of patients every 
year, the procedure is not always 
successful. A vessel may start to 
constrict again immediately follow-
ing the procedure or i t may do so 
several months after the treatment. 
The key to keeping threatened 
vessels open lies i n a flexible mesh 
cylinder about the size of a short 
chunk of pencil. These tubes, made 
from the metal t i tanium, are called 
stents. They are small and flexible 
enough to f i t snugly into a vessel 
that has been widened by balloon 
angioplasty, but that has not re-
sponded as w e l l as hoped. A n d once 
implanted, the stent devices are 
incorporated into the artery wal l . 
"The tissue l in ing the blood 
vessel grows through the mesh and 
coats the inside of the stent," 
explains D'Agostino. " I f you were 
to look inside an affected artery, it 's 
hard to tel l the stent is there." Yet 
whi le effectively invisible, the stent 
continues to keep the artery open— 
and the life-giving blood f lowing 
through the once obstructed vessel. 
Color doppler 
Ultrasound is sound that is too 
high pitched for the human ear to 
hear. I t is s t i l l sound, however, and 
a new radiologic technology is 
taking advantage of that fact to aid 
i n diagnosing everything from 
obstructed veins to some types of 
cancer. 
This new technology is called 
color doppler. I t is based on the fact 
that sound changes its pitch, f rom 
the listeher's standpoint, when i t 
speeds up or slows down. A n 
example of this is the way a train's 
whistle sounds to a listener near the 
track. As the train approaches, its 
whistle sounds high. Then, as i t 
speeds away, its whistle suddenly 
seems to drop i n pitch. I n fact, the 
sound has not changed. Its apparent 
drop stems f rom the fact that the 
train has gone f rom moving 
toward the listener to moving away. 
This phenomenon is called the 
doppler effect. 
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Ewa Kuligowska, M D , BUMCH's 
chief of ultrasound, says those same 
properties of sound can be hamessed 
i n imaging. I n this case, the " l is -
tener" is a special type of micro-
phone that is placed on the skin, 
and the moving element is the 
patient's bloodstream. Just as w i t h 
a train whistle, sound bounced back 
from blood cells that are moving 
away is lower pitched than that 
f rom approaching blood cells. 
A computer translates those two 
types of signals into colors: red for 
blood moving toward the micro-
phone (and, usually, away from the 
heart) and blue for blood moving 
away from the microphone. The 
system shows non-moving areas, as 
i n the area of an obstruction, as 
shades of gray. " I f a blood vessel is 
obstructed," explains Kuligowska, 
"we can see there is no blood 
movement f rom the absence of 
color and detect the obstruction." 
Color doppler is allowing 
B U M C H physicians to probe for 
blood clots that can plug veins 
buried deep w i t h i n the body. I t is 
also permitt ing cancer diagnoses. 
"Benign tumors usually develop few 
if any blood vessels," notes 
Kuligowska, "whereas malignant 
tumors, especially if they're aggres-
sive, have a large number of ves-
sels. By using color doppler, we can 
often te l l what k i n d of tumor we're 
dealing w i t h . " 
The technology already has been 
used i n distinguishing prostate 
cancers from the benign swelling of 
the prostate gland that is common 
i n men over age 50. The approach 
is less risky—and less costly—than 
a biopsy, says Kuligowska, who has 
conducted a number of studies of 
techniques for diagnosing and 
treating prostate cancer. 
The approach also can be used to 
distinguish ovarian cancers from 
non-cancerous problems l ike cysts. 
Great effort is also being put into 
applying the technique i n the 
detection of breast cancer. So far, 
color doppler is not accurate 
enough to spare women w i t h breast 
lumps the need for biopsies. 
However, Kuligowska notes that 
the technology is s t i l l new. "We're 
just leaming how to take advantage 
of color doppler," she says. " I n the 
near future, this is something that 
may replace many types of invasive 
techniques." 
FOR YOUR INFORMATION 
Dr. Yucel is the 
Hospital's 
director of 
vascular 
radiology and 
MRl, and an 
associate 
professor of 
radiology at Boston University 
School of Medicine. 
Dr. D'Agostino 
is a member of 
the BUMCH 
Department of 
Radiology and 
an instmctor at 
the School of 
Medicine. 
Dr. 
Kuligowska 
is the 
Hospital's 
chief of body 
imaging and 
ultrasound, 
and a 
professor of radiology at the 
School of Medicine. 
If you would like more informa-
tion on the radiologic services 
offered at BUMCH, please call 
617/638-6767 during business 
hours. 
Radiology 
fund 
established 
to fuel 
research, 
education 
Boston University School of 
Medicine's Department of 
Radiology has established a fund to 
support radiologic research and 
education at the Medical Center. 
The Francis H. Williams Fund for 
Radiologic Research and 
Education has been named in 
honor of America's first radiologist, 
who practiced at Boston City 
Hospital. 
Young physicians and radiologic 
physics investigators will be 
provided with the support needed to 
pursue high quality investigations in 
areas of magnetic resonance, 
electronic imaging, contrast media 
development, ultrasonography, 
interventional techniques, and new 
methods for extracorporeal lesion 
production. These areas are 
expected to define the dimensions of 
radiologic care for the rest of the 
decade. 
Resident house staff trainees will 
be afforded the opportunity for 
educational enhancement via library 
books and journal subscriptions, 
visiting professorships, travel to 
meetings, audiovisual teaching aids, 
and interactive computer programs. 
Those interested in contributing to 
this fund should contact James 
Chalmers, major gifts development 
officer, in tbe School of Medicine 
Office of Development, at 
617/638-4570. 
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Names... 
Joseph Loscalzo, 
MD, PhD 
Thomas J. Ryan, MD 
&) Joseph 
Loscalzo, MD, 
PhD, has become 
the Hospital's 
new chief of 
cardiology, 
succeeding 
Thomas J. Ryan, 
MD, who held the 
post for 22 years. 
Loscalzo comes to 
BUMCH from 
Harvard Medical 
School, where he 
was an associate 
professor of 
medicine. He 
also served as 
chief of cardiology 
at the Brockton/ 
West Roxbury VA 
Medical Center, director of the Center 
for Research in Thrombolysis at 
Brigham &t Women's Hospital and 
director of the International Society 
and Federation of Cardiology 
Thrombosis/Vascular Training Center 
at both institutions. A distinguished 
academician, Loscalzo is a member of 
the editorial boards of several promi-
nent journals and a member of the 
American Board of Intemal Medicine's 
Cardiovascular Diseases Test Com-
mittee. He also is the author of 
numerous original research reports and 
hooks. Loscalzo received his medical 
and PhD degrees from the University 
of Pennsylvania. 
Ryan, who remains an 
active member of BUMCH's 
clinical staff, is a past president 
of the American Heart Associa-
tion and the recipient of a 
number of significant profes-
sional honors. He has contrib-
uted extensively to the design 
and execution of randomized 
clinical trials, as well as to the 
development of clinical 
practice guidelines. Under his 
leadership, the cardiology 
service became one of the most 
respected in Boston and its 
fellowship training program 
gamered national recognition 
for overall excellence. 
Michael F. 
Holick, PhD, MD 
fames C. Melby, MD 
&) Michael F. Holick, PhD, MD, is 
BUMCH's new chief of endocrinology, 
diabetes and metabolism, succeeding 
James C. Melby, MD. Holick, chief of 
endocrinology, diabetes and metabolism 
at Boston City Hospital since 1989, 
has broad clinical research interests, 
ranging from the evolution of vitamin 
D to hone disease. He was recently 
appointed to a five-year post as 
chairman of the NASA Space Physiol-
ogy and Countermeasures Science 
Program. Melby, who retired as 
section chief this past summer after 31 
years of distinguished service to 
BUMC, made significant contributions 
to the understanding of the etiology 
and treatment of a number of diseases, 
especially essential hypertension. He 
is a past president of 
the Hospital's 
Medical-Dental Staff 
and remains an active 
member of the 
endocrine clinical 
staff. 
et> Neurology chief 
Robert G. Feldman, 
MD, was presented 
the 1993 Outstanding 
Research Award by 
the American 
Parkinson's Disease 
Association (APDA) 
at a program held this 
past fall at the Boston 
Museum of Science. 
The award was given 
BUMCH neurology chief 
Robert G. Feldman, MD, 
left, is presented the 1993 
Outstanding Research 
Award by Mario Esposito, 
president of the American 
Parkinson's Disease 
Association. 
in recognition of Feldman's many 
important contributions to the 
understanding and treatment of 
Parkinson's disease. At the same 
event, i t was announced that Feldman 
would lead a new, APDA-funded 
Advanced Center for Parkinson 
Research, to he founded at Boston 
University School of Medicine. The 
Center w i l l receive $100,000 per year 
in research funding from the APDA for 
the next five years. 
eP William B. Kannel, MD, a member 
of the Department of Medicine, 
recently was selected as the co-
recipient of the Third Annual Bristol-
Myers Squibb Award for Distinguished 
Achievement in Cardiovascular 
Research. Kannel, who is the former 
chief of the Section of Preventive 
Medicine and Lpidemiology, became 
the second director of the Boston 
University/Framingham Heart Study 
in 1966, having been associated with 
the study since its inception in 1949. 
&) Barry M. Manuel, MD, a member of 
the Department of Surgery, recently 
received the American College of 
Surgeons' highest honor, the Distin-
guished Service Award. Manuel, vice 
chairperson of the hoard of the 
Massachusetts Professional Insurance 
Association, was recognized for his 
dedication to working for medical 
liability reform and his work as a 
clinical surgeon. 
&> Joseph T. Ferrucci Jr., MD, chief of 
the Department of Radiology, has been 
named vice president of the American 
College of Radiology through 1994. 
&> Jeffrey H. Samet, MD, MPH, a 
member of the Department of Medi-
cine, was one of 15 physicians across 
the country this past summer to 
receive a four-year Generalist Physi-
cian Faculty Scholars grant from the 
Robert Wood Johnson Foundation, the 
nation's largest health care philan-
thropy. 
&) BUMCH Vice President for 
Nursing Maura Mitchell, RN, MEd, 
has been appointed the executive 
director of nursing for Boston's 
Department of Health and Hospitals. 
Mitchell w i l l continue to serve in her 
BUMCH position, while performing in 
this new post. 
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&) Anesthesiology chief 
Marcelle Willock, MD, has 
heen elected president-elect 
of the Society of Academic 
Anesthesiology Chairs. 
&> Harold L. Lazar, MD, a 
member of the Department 
of Cardiothoracic Surgery, 
has heen appointed secre-
tary of the Section of 
Cardiac Surgery of the 
American College of Chest 
Physicians. 
&) Robert E. Leach, MD, a 
member of the Department of Ortho-
pedic Surgery and its former chief, has 
heen installed as the 107th president of 
the American Orthopaedic Associa-
tion. 
€i) Alan S. Cohen, MD, the founder 
and director of Boston University 
School of Medicine's Arthritis Center, 
is the editor-in-chief and founder of a 
new journal called Amyloid. The 
International Journal of Experimental 
and Clinical Investigation. The 
publication w i l l he hased at the School 
of Medicine and its editorial hoard w i l l 
he comprised of several BUSM faculty 
members. 
€t> Jay R. Wein became the Hospital's 
new vice president for development 
last summer. He is the former 
principal of Wein Associates, Inc., a 
Brookline-hased, fund-raising consult-
ing firm. Before founding Wein 
Associates, he served as director of 
development and public relations for 
the Joslin Diabetes Center. 
&> The Hospital Corporation, at its 
I39th annual meeting in December, 
elected new trustees Timothy J. 
Barberich, Stephen G. Kasnet, Julie 
Kertzmau and James F. Marten, PhD. 
It also elected new overseer Barbara A. 
Piette. 
BUMC held the first in a series of open forums on 
health care reform this past fail. The seven panelists 
spoke to a standing-room only crowd. 
cal/hiotechnology complex planned 
for Albany Street by Boston Univer-
sity and BUMC Hospital. When 
completed, the "scientific village" is 
expected to he the largest and most 
comprehensive health care and 
biotechnology development in Boston. 
eh Leaders from Boston University 
Medical Center and the local health 
care community gathered to discuss 
News. 
&) Some 300 people turned out to 
celebrate the official opening of Boston 
University's new Center for Advanced 
Biomedical Research on Oct. 14, at the 
site of the new building at 700 Albany 
St. The Center is the first structure 
in BioSquare, a $350 million, hiomedi-
their assessment of the Clinton health 
care reform plan this past fall, in what 
was the first of a series of forums on the 
issue to he held at the Medical Center. 
The seven panelists spoke to a stand-
ing-room only crowd of employees, 
students, faculty and administrators. 
eh The Hospital broke ground on Sept. 
10 for the RLN Center-Boston Dialysis 
Clinic, an outpatient dialysis facility 
located two blocks from the Hospital. 
The Center is expected to open in mid 
1994, in a three-story, 33,000-square-
foot brick building. 
&) Some 73 members of the Hospital's 
Medical-Dental Staff commemorated 
their anniversaries of service to 
BUMCH during the 12th annual 
Medical-Dental Staff Recognition 
Brunch, held on Oct. 31, at Boston's 
Park Plaza Hotel. Some 325 people 
attended this year's event, where 
service-recognition awards ranging from 
five to 45 years were conferred. 
'We need more 
friends like you' 
m 
Abercromhie, Balady, Collins, 
BUMCH trustee James Lowell 2nd, 
and Collins' wife, Anne, (left to right) 
gather outside the newly dedicated 
conference room. ,,«:: ;,v,::,i, 
Webster Collins is a former patient who is 
thankful to BUMCH from the bottom of his 
heart, almost literally. 
Not long after he first was treated at the 
Hospital in 1985, Collins began supporting 
its Cardiac Rehabilitation Program with 
financial donations. In recognition of his 
generosity, the Webster A. Collins 
Conference Room, located on the third floor of the Preston Family Building (Preston 3), 
was recently dedicated in his honor. Collins, an executive vice president and partner of 
Whittier Partners, a Boston-based real estate management and consulting firm, chose 
BUMCH as his rehabilitation site after having bypass surgery elsewhere. 
"Mr. Collins really is a model, heart-healthy patient. He eats right, exercises and 
watches his weight," says Hospital cardiologist Gary Balady, MD, director of the Cardiac 
Rehabilitation Program. "Considering his overwhelming commitment, it is fitting that we 
dedicate in his honor a room that is an important focal point of patient-education 
activities." 
Collins' most recent gift enabled the rehab program to purchase a state-of-the-art 
stress test system for the Hospital's Cardiovascular Exercise Center, also located on 
Preston 3. With the new system, patients can he better monitored throughout an 
exercise stress test, which is designed to determine a patient's proper level of healthful 
exercise. 
"The Hospital needs more friends like you," Hospital President J. Scott Abercromhie 
Jr., MD, told Collins during the dedication ceremony. "In these constantly changing 
times, philanthropy is more important than ever." 
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LOOKING FOR AN I R A 
SUBSTITUTE? 
Is your retirement aecount yielding only 2 to 3 percent? Want to 
know where to put your money i n order to obtain a better r e t u m 
and increased retirement income? If so, you should consider 
investing i n a B U M C H deferred gift annuity. 
A B U M C H deferred gift annuity provides you w i t h a high rate 
of retum, as w e l l as a substantial charitable tax deduction. For 
example, a gift of $10,000 made by a 40-year-oid donor cams... 
• 27.1 percent i n annual income, or $2,710, beginning at age 65; 
• an immediate charitable tax deduction of $5,778.40, and 
• a tax savings on the annuity income, since you w i l l l ikely he 
i n a lower tax bracket at age 65. 
Most importantly, on top of these benefits, your gift w i l l 
benefit the B U M C H program or department of your choice. 
For a personalized printout showing how you can benefit from a 
deferred gift annuity, please complete and retum the coupon 
below to fames Woodmff, planned and major gifts officer, Boston 
University Medical Center Hospital, Development Office, 88 East 
Newton St., Boston, MA 02118, or call 617/638-8943. 
1 am interested i n leaming more about deferred gift annuities. Please send me a personalized 
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State-of'the-Art Corneal Mapping 
Teehmlogfhas given BU Medical 
Center Hospital ophthalmologists 
the ability to locate troubling astig-
matism w i t h precision. Equipped 
wi th this ''road map" of tbe cornea, 
BUMCH ophthalmologists are able 
to surgically correct astigmatism 
and help restore tbe vision of those 
who suffer from this common yet 
disabling ocular problem. 
See story on page 2. 
